Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Meteora Capital, LLC | 5.37M | $1.0M | 3.38% | -- | 2026-06-30 |
| CITADEL ADVISORS LLC | 5.17M | $1.0M | 3.25% | +4.65M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.04M | -- | 1.91% | +2.46M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.03M | -- | 0.65% | +286.7K | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 641.7K | -- | 0.40% | +270.0K | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 457.1K | -- | 0.29% | +22.5K | 2026-06-30 |
| STATE STREET CORP | 302.5K | -- | 0.19% | +106.1K | 2026-06-30 |
| UBS Group AG | 264.3K | -- | 0.17% | -808.7K | 2026-06-30 |
| NORTHERN TRUST CORP | 247.4K | -- | 0.16% | +169.4K | 2026-06-30 |
| AM INVESTMENT STRATEGIES LLC | 200.0K | -- | 0.13% | -- | 2026-06-30 |
